220 related articles for article (PubMed ID: 23684830)
41. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
42. Cutaneous immunization: an evolving paradigm in influenza vaccines.
Gill HS; Kang SM; Quan FS; Compans RW
Expert Opin Drug Deliv; 2014 Apr; 11(4):615-27. PubMed ID: 24521050
[TBL] [Abstract][Full Text] [Related]
43. Current opportunities and challenges in intradermal vaccination.
Chen D; Bowersock T; Weeratna R; Yeoh T
Ther Deliv; 2015; 6(9):1101-8. PubMed ID: 26458019
[TBL] [Abstract][Full Text] [Related]
44. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
45. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
46. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
Teunissen MB; Haniffa M; Collin MP
Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
[TBL] [Abstract][Full Text] [Related]
47. New vaccination technologies that make needles redundant.
Senior K
Lancet Infect Dis; 2011 Jan; 11(1):16-7. PubMed ID: 21226239
[No Abstract] [Full Text] [Related]
48. Immunity under the skin: potential application for topical delivery of vaccines.
Partidos CD; Beignon AS; Mawas F; Belliard G; Briand JP; Muller S
Vaccine; 2003 Jan; 21(7-8):776-80. PubMed ID: 12531358
[TBL] [Abstract][Full Text] [Related]
49. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
50. Animal models for cutaneous vaccine delivery.
Hirschberg HJ; van Riet E; Oosterhoff D; Bouwstra JA; Kersten GF
Eur J Pharm Sci; 2015 Apr; 71():112-22. PubMed ID: 25686596
[TBL] [Abstract][Full Text] [Related]
51. Antigens onto bare skin: a 'painless' paradigm shift in vaccine delivery.
Partidos CD
Expert Opin Biol Ther; 2003 Sep; 3(6):895-902. PubMed ID: 12943448
[TBL] [Abstract][Full Text] [Related]
52. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
[TBL] [Abstract][Full Text] [Related]
53. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
Naito S; Ito Y; Kiyohara T; Kataoka M; Ochiai M; Takada K
Vaccine; 2012 Feb; 30(6):1191-7. PubMed ID: 22172508
[TBL] [Abstract][Full Text] [Related]
54. Intradermal needle-free powdered drug injection by a helium-powered device.
Liu J; Hogan NC; Hunter IW
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():2068-71. PubMed ID: 23366327
[TBL] [Abstract][Full Text] [Related]
55. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
[TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults.
Laurent PE; Bourhy H; Fantino M; Alchas P; Mikszta JA
Vaccine; 2010 Aug; 28(36):5850-6. PubMed ID: 20600481
[TBL] [Abstract][Full Text] [Related]
57. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
58. Understanding the basis of transcutaneous vaccine delivery.
Gamazo C; Pastor Y; Larrañeta E; Berzosa M; Irache JM; Donnelly RF
Ther Deliv; 2019 Jan; 10(1):63-80. PubMed ID: 30730825
[TBL] [Abstract][Full Text] [Related]
59. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine.
Kim NW; Lee MS; Kim KR; Lee JE; Lee K; Park JS; Matsumoto Y; Jo DG; Lee H; Lee DS; Jeong JH
J Control Release; 2014 Apr; 179():11-7. PubMed ID: 24462900
[TBL] [Abstract][Full Text] [Related]
60. DNA vaccines and intradermal vaccination by DNA tattooing.
Oosterhuis K; van den Berg JH; Schumacher TN; Haanen JB
Curr Top Microbiol Immunol; 2012; 351():221-50. PubMed ID: 21107792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
